# Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

> **NCT05292859** · — · COMPLETED · sponsor: **Alaunos Therapeutics** · enrollment: 7 (actual)

## Conditions studied

- Gynecologic Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Non-small Cell Lung Cancer
- Cholangiocarcinoma
- Ovarian Cancer
- Ovary Neoplasm
- Squamous Cell Lung Cancer
- Adenocarcinoma of Lung
- Adenosquamous Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Neoantigen specific TCR-T cell drug product

## Key facts

- **NCT ID:** NCT05292859
- **Lead sponsor:** Alaunos Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292859, "Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05292859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*